Taiwan · Delayed Price · Currency is TWD Orient EuroPharma Statistics
Total Valuation
TPEX:4120 has a market cap or net worth of TWD 4.28 billion. The enterprise value is 6.55 billion.
| Market Cap | 4.28B |
| Enterprise Value | 6.55B |
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Jul 7, 2025 |
Share Statistics
TPEX:4120 has 86.75 million shares outstanding. The number of shares has decreased by -0.23% in one year.
| Current Share Class | 86.75M |
| Shares Outstanding | 86.75M |
| Shares Change (YoY) | -0.23% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.69% |
| Owned by Institutions (%) | 1.39% |
| Float | 31.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.95 |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | 176.43 |
| P/OCF Ratio | 22.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 108.45, with an EV/FCF ratio of 269.78.
| EV / Earnings | -20.27 |
| EV / Sales | 1.46 |
| EV / EBITDA | 108.45 |
| EV / EBIT | n/a |
| EV / FCF | 269.78 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.39 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 32.67 |
| Debt / FCF | 144.85 |
| Interest Coverage | -0.91 |
Financial Efficiency
Return on equity (ROE) is -4.40% and return on invested capital (ROIC) is -0.53%.
| Return on Equity (ROE) | -4.40% |
| Return on Assets (ROA) | -0.46% |
| Return on Invested Capital (ROIC) | -0.53% |
| Return on Capital Employed (ROCE) | -1.00% |
| Revenue Per Employee | 13.23M |
| Profits Per Employee | -952,711 |
| Employee Count | 339 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.94 |
Taxes
In the past 12 months, TPEX:4120 has paid 219.58 million in taxes.
| Income Tax | 219.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.34% in the last 52 weeks. The beta is 0.22, so TPEX:4120's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +1.34% |
| 50-Day Moving Average | 50.90 |
| 200-Day Moving Average | 50.34 |
| Relative Strength Index (RSI) | 44.71 |
| Average Volume (20 Days) | 49,073 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4120 had revenue of TWD 4.48 billion and -322.97 million in losses. Loss per share was -3.72.
| Revenue | 4.48B |
| Gross Profit | 2.13B |
| Operating Income | -91.05M |
| Pretax Income | -62.74M |
| Net Income | -322.97M |
| EBITDA | 64.46M |
| EBIT | -91.05M |
| Loss Per Share | -3.72 |
Balance Sheet
The company has 1.93 billion in cash and 3.51 billion in debt, giving a net cash position of -1.59 billion or -18.30 per share.
| Cash & Cash Equivalents | 1.93B |
| Total Debt | 3.51B |
| Net Cash | -1.59B |
| Net Cash Per Share | -18.30 |
| Equity (Book Value) | 6.88B |
| Book Value Per Share | 71.48 |
| Working Capital | 1.22B |
Cash Flow
In the last 12 months, operating cash flow was 188.25 million and capital expenditures -163.98 million, giving a free cash flow of 24.27 million.
| Operating Cash Flow | 188.25M |
| Capital Expenditures | -163.98M |
| Free Cash Flow | 24.27M |
| FCF Per Share | 0.28 |
Margins
Gross margin is 47.60%, with operating and profit margins of -2.03% and -7.20%.
| Gross Margin | 47.60% |
| Operating Margin | -2.03% |
| Pretax Margin | -1.40% |
| Profit Margin | -7.20% |
| EBITDA Margin | 1.44% |
| EBIT Margin | -2.03% |
| FCF Margin | 0.54% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.23% |
| Shareholder Yield | 2.25% |
| Earnings Yield | -7.54% |
| FCF Yield | 0.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.
| Last Split Date | Jul 28, 2010 |
| Split Type | Forward |
| Split Ratio | 1.16 |
Scores
TPEX:4120 has an Altman Z-Score of 1.32 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | 4 |